Observed Efficacy With Subcutaneous Tanezumab Is Early And Maintained In Patients With Osteoarthritis: Results From A 56-Week Randomized Nsaid-Controlled Study
ARTHRITIS & RHEUMATOLOGY(2020)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined